![]() |
|
|
Vol. 298, Issue 2, 539-550, August 2001
National Public Health Institute, Department of Mental Health and
Alcohol Research, Drug Research Unit, Helsinki, Finland
In drug addiction, a sensitization phenomenon has been postulated to
play a critical role. The aim of our study was to evaluate whether
sensitization occurs to the rewarding properties of methylphenidate, a
psychostimulant drug known to possess abuse potential, as assessed with
the biased conditioned place preference method in rats. In addition,
since the brain dopaminergic system is considered to be important in
drug-reward, the involvement of dopamine D1- and D2-receptors both in
the rewarding properties of methylphenidate and in sensitization to
these properties was assessed. Conditioning with methylphenidate at
doses of 1.25 to 20 mg/kg increased preference for the paired
environment, whereas a dose of 0.31 mg/kg was ineffective. However,
following the 7-day sensitization treatment with methylphenidate (0.62-20 mg/kg), conditioning with a dose of 0.31 mg/kg resulted in an
increased preference for the paired environment, i.e., the rewarding
properties of methylphenidate appeared to be sensitized. Control
experiments indicated that the enhancement of preference was not due to
attenuation of sensitization treatment-induced withdrawal nor to
tolerance to aversive properties of methylphenidate. When conditioned
with methylphenidate, D1-antagonist SCH 23390 but not D2-antagonist
raclopride prevented place preference. However, when coadministered
with methylphenidate during the sensitization treatment, both SCH 23390 and raclopride prevented the development of sensitization. These data
indicate that the rewarding properties of methylphenidate are
sensitized by prior exposure to the drug and that both D1- and
D2-receptors, the latter of which possibly more specifically, appear to
be involved in the development of this sensitization.